Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Bial - Portela & CA. S.A. v. Alkem Laboratories Ltd., No. 23-1235 (Fed. Cir. Feb. 6, 2023)

Dismissed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 23-1235
Decided
February 6, 2023
Judge
See opinion
Document
Order on Motion
Length
2 pages

NOTE: This order is nonprecedential. United States Court of Appeals

for the Federal Circuit BIAL - PORTELA & CA. SA, BIAL - HOLDING,

SA, SUNOVION PHARMACEUTICALS INC.,

Plaintiffs-Cross-Appellants

v.

ALKEM LABORATORIES LTD.,

Defendant-Appellant

2023-1235, 2023-1237, 2023-1239, 2023-1240

Appeal from the United States District Court for the District of Delaware in No. 1:20-cv-00786-CFC-CJB, 1:18-cv-00304-CFC-CJB, 1:21-cv-00186-CFC, Chief Judge Colm F. Connolly.

ON MOTION

O R D E R

The parties submit a “Joint Stipulation to Dismiss Appeals,” which the court treats as a joint motion to dismiss these appeals.

Upon consideration thereof,

22 BIAL - PORTELA & CA. SA V. ALKEM LABORATORIES LTD.

IT IS ORDERED THAT

(1) The motion is granted. The appeals are dismissed. (2) Each side shall bear its own costs.

FOR THE COURT

February 6, 2023

Date /s/ Peter R. Marksteiner

Peter R. Marksteiner Clerk of Court ISSUED AS A MANDATE: February 6, 2023

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Bial - Portela & CA. S.A. v. Alkem Laboratories Ltd., No. 23-1235 (Fed. Cir. Feb. 6, 2023).

Record ID
CAFC-23-1235-20230206
Permalink
https://patentcasewatch.com/opinions/CAFC-23-1235-20230206

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.